Drug class
Amidinopenicillin beta-lactam antibacterial; preferential PBP2 inhibitor
Mechanism of action
Binds penicillin-binding protein 2 (PBP2), inhibiting bacterial cell-wall peptidoglycan synthesis and producing bactericidal activity, particularly against susceptible Enterobacterales.
General use cases
- Treatment of uncomplicated urinary-tract infection caused by susceptible organisms, particularly Escherichia coli, in countries where oral pivmecillinam is authorised; the oral prodrug formulation and its dose are product-specific
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
